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ABSTRACT
In the context of covid-19, aerosol generating procedures 
have been highlighted as requiring a higher grade of 
personal protective equipment. We investigated how 
official guidance documents and academic publications 
have classified procedures in terms of whether or not they 
are aerosol- generating. We performed a rapid systematic 
review using preferred reporting items for systematic 
reviews and meta- analyses standards. Guidelines, policy 
documents and academic papers published in english or 
french offering guidance on aerosol- generating procedures 
were eligible. We systematically searched two medical 
databases (medline, cochrane central) and one public 
search engine (google) in march and april 2020. Data on 
how each procedure was classified by each source were 
extracted. We determined the level of agreement across 
different guidelines for each procedure group, in terms of 
its classification as aerosol generating, possibly aerosol- 
generating, or nonaerosol- generating. 128 documents 
met our inclusion criteria; they contained 1248 mentions 
of procedures that we categorised into 39 procedure 
groups. Procedures classified as aerosol- generating 
or possibly aerosol- generating by ≥90% of documents 
included autopsy, surgery/postmortem procedures with 
high- speed devices, intubation and extubation procedures, 
bronchoscopy, sputum induction, manual ventilation, 
airway suctioning, cardiopulmonary resuscitation, 
tracheostomy and tracheostomy procedures, non- invasive 
ventilation, high- flow oxygen therapy, breaking closed 
ventilation systems, nebulised or aerosol therapy, and high 
frequency oscillatory ventilation. Disagreements existed 
between sources on some procedure groups, including oral 
and dental procedures, upper gastrointestinal endoscopy, 
thoracic surgery and procedures, and nasopharyngeal 
and oropharyngeal swabbing. There is sufficient evidence 
of agreement across different international guidelines to 
classify certain procedure groups as aerosol generating. 
However, some clinically relevant procedures received 
surprisingly little mention in our source documents. To 
reduce dissent on the remainder, we recommend that (a) 
clinicians define procedures more clearly and specifically, 
breaking them down into their constituent components 
where possible; (b) researchers undertake further studies 
of aerosolisation during these procedures; and (c) 
guideline- making and policy- making bodies address a 
wider range of procedures.
INTRODUCTION
Humans ordinarily expel particles from the 
mouth and nose while breathing, talking and 
coughing, as well as during certain health-
care procedures. These particles are formed 
of water and mucus that contain infectious 
material, including viruses. Exhaled particles 
may range in size between 0.01 and 1000 µm, 
depending on mechanism of generation and 
site of origin, with up to 308 600 particles 
being produced per cough.1 2 Procedures 
(eg, intubation) can change the volume, size, 
distribution and speed of particles expelled as 
well as changing their origin from different 
parts of the respiratory tract.
Viruses lose viability at different rates, 
depending on the virus family and func-
tional surface characteristics, droplet expul-
sion mode and stability, environment, and 
time.3–5 Susceptible persons in the vicinity of 
an infected individual can therefore become 
infected through multiple particle routes, 
including inhaling close to the source or 
touching and transferring particles that have 
landed on surfaces. Expelled particles can 
spread widely in a room in a short time after a 
cough,6–8 and cases are recorded where infec-
tious material has dispersed through ventila-
tion systems or windows.9 Infectious particles 
may also be dispersed by other routes such 
as toilet flushing or doffing protective 
clothing.10 11
Infection control practices have tradition-
ally classified disease transmission as occur-
ring through ‘contact’ (implying direct 
physical transfer), ‘droplet’ or ‘airborne’ 
routes.12 Larger particles settle in a reason-
ably short distance, and are referred to as 
‘droplets’ in the infection control context. 
Smaller particles can travel as aerosols on air 
currents, remaining in the air for longer and 
distributing over a wide area.13
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Severe acute respiratory syndrome coronavirus 2 
(SARS- CoV-2), the virus that causes coronavirus disease 
2019 (COVID-19) can be transmitted via aerosols.14 
Therefore, medical procedures that generate aero-
sols can lead to transmission of the virus to personnel 
performing the procedures as well as to bystanders. For 
that reason, physicians and other healthcare providers 
are understandably concerned about aerosol- generating 
procedures, infection risk and the need for appropriate 
personal protective equipment.15 16
Infection control practices include wearing an appro-
priate ensemble of personal protective equipment as well 
as using proper procedures for donning and doffing. 
The critical items of personal protective equipment in 
relation to aerosolised infectious matter are respiratory 
protective devices, specifically filtering facepiece respira-
tors such as FFP2, FFP3 or N95 type masks. These should 
be used together with other items as appropriate, such as 
gloves, gowns, shoe covers and eye protection equipment. 
Furthermore, personal protective equipment should be 
applied together with other hazard control measures in 
the hierarchy of controls, such as cohorting COVID-19 
positive patients, surface cleaning and ensuring adequate 
air ventilation.17 18
The WHO and other authorities recommend the 
use of respirators when performing aerosol- generating 
procedures on patients with known or suspected COVID-
19, but deem standard surgical masks (which do not seal 
to the face and are not considered respirators) adequate 
for routine care not involving aerosol- generating proce-
dures.12 The question of what is or is not an aerosol- 
generating procedure is therefore of considerable 
importance in the COVID-19 context, especially when 
certain items of personal protective equipment, such as 
filtering facepiece respirators, are in short supply.
Our specific research question was: how have official 
guidance documents and academic publications clas-
sified procedures in terms of whether or not they are 
aerosol- generating?
METHODS
We conducted a rapid systematic review in line with the 
Cochrane Interim Guidance for Rapid Reviews.19 Our 
review was registered as a COVID-19 Rapid Evidence 
Review with the National Collaborating Centre for 
Methods and Tools at McMaster University (https://www. 
nccmt. ca/ knowledge- repositories/ covid- 19- evidence- 
reviews/ 7).
We have reported this review according to the Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analyses reporting criteria for systematic reviews where 
appropriate (online appendix 1).20 Our review is part of 
a ‘Programme of Research and Training in Occupational 
Medicine’ by SSt’s team at the University of Alberta. It 
is also one of a suite of reviews on personal protective 
equipment initially commenced as part of the Oxford 
COVID-19 evidence series and edited by TG.
We included documents in English or French (read 
fluently by the authors, reflecting Canada’s bilingualism) 
and published since 1 January 2000. We deemed eligible 
for inclusion peer- reviewed journal articles, pre- prints, 
conference proceedings and grey literature from a variety 
of sources such as healthcare organisations, agencies and 
government departments. To be included, documents 
had to report on procedures and state whether they are 
aerosol- generating, possibly aerosol- generating or not 
aerosol- generating.
Systematic literature searching was conducted from 
26 March 2020 to 8 April 2020. We searched for rele-
vant literature in Medline (1946 to present via OVID), 
in Cochrane Central (from inception to present) and 
in Google using English and French keywords, as well 
as performing searches on English and French websites. 
These search strategies are detailed in online appendix 
2. We also considered documents previously known to 
the authors, or that were shared with us by others after 
we had made known our intention of writing the present 
systematic review.
A data extraction form was developed and piloted, and 
used to extract citation details, definitions of aerosol- 
generating procedures used in the source documents 
and lists of procedures that were classified (as aerosol- 
generating, possibly aerosol- generating or not aerosol- 
generating). Extracted data for each source document 
were verified by a second researcher, and any discrepan-
cies found in the verification stage were adjudicated by a 
third researcher. Quantitative data on procedures iden-
tified as aerosol- generating, possibly aerosol- generating 
or not aerosol- generating were then generated by giving 
procedures one count for each document in which they 
were thus classified.
Different source documents used slightly different 
terminology to describe procedures. We combined 
similar procedures into a total of 39 procedure groups 
based on author consensus, using an iterative process 
of categorising the records and creating groups until 
we felt that the existing groups sufficiently captured 
the data. The resulting procedure groups are shown in 
table 1.
For aerosol- generating procedures, we developed 
groupings of likely aerosol sources using the same 
process, resulting in 12 aerosol source groups (table 2).
For each procedure group, we calculated the 
percentage of agreement among the contributing 
sources on how it was classified (aerosol- generating, 
possibly aerosol- generating, or not aerosol- generating). 
We considered 90% or greater agreement on a proce-
dure group as aerosol- generating or possibly aerosol- 
generating as very strong consensus, and 80% or greater 
agreement as strong consensus. Where there was a high 
level of disagreement between sources, or where a proce-
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Our searches identified 162 potentially eligible docu-
ments of which 153 remained after elimination of 
duplicates. Of these, 25 documents were excluded 
because they did not meet the eligibility criteria, leaving 
128 documents that were included in our rapid system-
atic review. Online appendix 3 lists the references of 
the included documents. Online appendix 4 details the 
excluded documents.
We used documents from nine countries including 
Canada (n=60), UK (n=9), France (n=8), USA (n=4), 
Australia (n=2), Ireland (n=2), Luxembourg (n=2), China 
(n=1) and New Zealand (n=1), as well as two documents 
from European agencies and societies and six documents 
from the WHO. We did not assign a country of origin for 
academic journal publications. Our included documents 
comprised 91 documents in English and 37 documents 
in French. The documents were from academic journals 
(n=31), supranational agencies (eg, the WHO) (n=7), 
government agencies (including regional and federal 
health boards and departments dedicated to public 
health, infection prevention, seniors’ health and long- 
term care, paediatric health and critical illness) (n=72) 
and professional associations (respiratory therapists and 
physiotherapists predominating) (n=17). Most included 
documents were published within the last five years.
Forty- three of the 128 documents in our sample 
provided definitions of aerosol- generating procedures, 
as listed in online appendix 5. These documents gener-
ally agreed that an aerosol- generating procedure was any 
intervention or procedure that could produce aerosols 
capable of transmitting diseases. Some documents spec-
ified that these interventions had to involve manipu-
lation of a patient’s airway, while others did not. Some 
documents also specified that aerosol- generating proce-
dures were only those procedures capable of producing 
aerosols in excess of what is produced when a patient is 
coughing, breathing or talking, while others made no 
mention of such a threshold.
The top 10 procedure groups classified as aerosol- 
generating, by greatest number of mentions across all 
included source documents (ie, a frequency count), 
were: intubation and extubation procedures, airway 
Table 1 Procedure groups
1 Airway suctioning
2 Autopsy







9 ENT and neurosurgery
10 Nitrous oxide (Entonox) administration
11 GI endoscopy (not further specified)
12 Handling soiled laundry
13 High- frequency oscillatory ventilation
14 High- flow oxygen therapy
15 Intra/extra pulmonary high- frequency oscillation 
devices
16 Intubation and extubation procedures
17 Labour and delivery
18 Lung function testing
19 Manipulation of masks
20 Manual ventilation
21 Mechanical ventilation
22 Mechanical insufflation and exsufflation
23 Nasogastric tube insertion
24 Nasopharyngeal aspirate
25 Nasopharyngeal and oropharyngeal swabbing
26 Nasopharyngoscopy or laryngoscopy
27 Nebulised or aerosol therapy
28 Non- invasive ventilation
29 Oral and dental procedures
30 Prone positioning
31 Sputum induction
32 Suction of body fluids (not further specified)
33 Supraglottic airways
34 Surgery/postmortem procedures with high- speed 
devices
35 Thoracic surgery and procedures
36 Toilet use and flushing
37 Tracheostomy and tracheostomy procedures
38 Upper GI endoscopy
39 Vacuum cleaning
ENT, ear, nose and throat; GI, gastrointestinal.
Table 2 Aerosol source groups
1 Autopsy
2 Cleaning tasks
3 Gastrointestinal (not further specified)
4 Inhaled therapy
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suctioning, bronchoscopy, non- invasive ventilation, 
nebulised or aerosol therapy, cardiopulmonary resus-
citation, sputum induction, tracheostomy and trache-
ostomy procedures, manual ventilation, and autopsy. 
These and further procedure groups are presented in 
online appendix 6. The likely aerosol sources for the 
procedures listed as aerosol- generating were assigned 
by us as follows: tracheobronchial (n=711 procedure 
mentions), inhaled therapy (n=111), oronasal (n=81), 
autopsy (n=33), wound/invasive procedure (n=27), 
cleaning tasks (n=13), patient care (n=13), upper gastro-
intestinal (GI) (n=5), GI—not further specified (n=2), 
laboratory (n=2) and lower GI (n=1). Online appendix 
7 details all mentions of the procedures deemed to be 
aerosol- generating.
The top 10 procedure groups listed as possibly aerosol- 
generating were: chest physiotherapy, nasopharyngeal 
aspirate, nasopharyngeal and oropharyngeal swabbing, 
nebulised or aerosol therapy, high- frequency oscillatory 
ventilation, non- invasive ventilation, tracheostomy and 
tracheostomy procedures, airway suctioning, coughing, 
intubation and extubation procedures, and mechanical 
ventilation. These, further procedure groups, and the 
associated frequency counts are presented in online 
appendix 8. The likely aerosol sources for the possible 
aerosol- generating procedures were: tracheobronchial 
(n=74 procedure mentions), oronasal (n=26), inhaled 
therapy (n=17), wound/invasive procedure (n=5) and 
patient care (n=3). Online appendix 9 lists all proce-
dures described as possibly aerosol- generating proce-
dures in the source documents. Online appendices 10 
and 11 present data on procedures which were deemed 
by the source documents to not be aerosol- generating. 
For these procedures, we assigned no aerosol source.
Ambiguity in procedure classification
The nature of a given procedure was sometimes ambig-
uous, making its assignment to a procedure group diffi-
cult. This was discussed at length among the authors 
and led to several iterative refinements of the procedure 
groups, careful review and sometimes reassignment of 
procedures to procedure groups.
For example, an Oxylator (a portable ventilator 
powered by an oxygen cylinder and used in cardiopul-
monary resuscitation) may be used with either manual or 
mechanical ventilation. In such cases, we assigned what 
we felt was the predominant group; for example, manual 
ventilation, in the case of the Oxylator.
Another challenge was ambiguous description. This 
was a common issue in procedures relating to suctioning. 
Some source documents used the specific term ‘airway 
suctioning’, while others listed a procedure as ‘suctioning’ 
or ‘open suction’, without an anatomical location. In 
some documents, ‘open suction’ was listed within respi-
ratory physiotherapy interventions, included in a section 
discussing respiratory droplets, or clearly listed along-
side other respiratory procedures (especially intubation, 
extubation and tracheostomy procedures), allowing us 
to classify it confidently as ‘airway suctioning’. In other 
documents, the term ‘suction’ was found in a heteroge-
neous list (eg, before ‘intubation’ but after ‘autopsy’). 
In these cases, we could not comfortably assume that 
‘suction’ necessarily meant airway suctioning. Several 
documents used the term ‘suction of body fluids’ as a 
procedure, but we could not find any context clues indi-
cating which body fluids were being suctioned; we there-
fore grouped those procedures as ‘suction of body fluids 
(not further specified)’. Online appendix 12 details this 
reasoning further.
The determination of the aerosol source was also some-
times open to interpretation. For example, we assigned 
an aerosol source of ‘oronasal’ to the procedure group 
‘nasopharyngoscopy or laryngoscopy’, as we deemed this 
the most likely source of aerosol. However, if such proce-
dures trigger a cough, then aerosols of ‘tracheobron-
chial’ origin would be generated.
Procedure groups with high consensus
Table 3 lists the 14 procedure groups on which there 
was very strong (90% or more) consensus among source 
documents that the constituent procedures were defini-
tively aerosol- generating or possibly aerosol- generating. 
It also lists three additional groups of procedures (high- 
frequency oscillatory ventilation, coughing and mechan-
ical ventilation) for which there was strong (80% or 
more) consensus. As shown in column 3 of table 3, some 
of these procedures were mentioned in most of the source 
documents, while others were mentioned less often.
Procedure groups with poor consensus
Table 4 lists four groups of procedures on which there 
was less than 80% consensus. In one of these (oral and 
dental procedures), consensus was 78%. In the other 
three (upper GI endoscopy, thoracic surgery and proce-
dures, and nasopharyngeal and oropharyngeal swab-
bing), there appeared to be substantial disagreement 
among sources. Possible reasons for disagreement are 
considered in the Discussion section.
For the controversial procedure groups, one needs to 
look in more detail; for example, for the oral and dental 
procedures group, which we recognise is heterogeneous, 
the procedures deemed to be aerosol- generating often 
specified the use of a high- speed device, including the 
use of air turbines, air/water syringes, scopes, high- speed 
drills, or other power tools or high- speed handpieces; 
and the use of ultrasonic scalers. Other oral and dental 
procedures described as aerosol- generating included 
dental care, dental examinations and the use of propel-
lant anaesthetic freezing sprays such as oral lidocaine.
In contrast, oral and dental procedures labelled as not 
aerosol- generating did not specify the use of high- speed 
devices. We found the following procedures listed as not 
aerosol- generating: dental examinations, oral suctioning 
or suctioning of the oropharynx, hand scaling with 
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suction, non- surgical extractions, removable denture 
stages, removal of caries using hand excavation or a slow- 
speed handpiece, and orogastric tube placement.
Procedure groups with very limited evidence
Table 5 lists 15 groups of procedures which were each 
mentioned in fewer than 10 source documents. Some 
of these (eg, ear, nose and throat and neurosurgery) 
were classified as aerosol- generating procedures when-
ever they were mentioned while others (such as naso-
gastric tube insertion) were classified inconsistently as 
Table 3 Procedure groups classified as ‘aerosol- generating’ or ‘possibly aerosol- generating’ with high levels of agreement 
(80% or more of sources)
Procedure group Aerosol source




n (%) of sources that 
classified procedures 
in this group as 
aerosol- generating
n (%) of sources that 
classified procedures in 
this group as possibly 
aerosol- generating
n (%) of sources that 
classified procedures 
in this group as not 
aerosol- generating
Autopsy Autopsy 33 33 (100) 0 (0) 0 (0)
Surgery/postmortem procedures 
with high- speed devices
Wound/invasive 
procedure
14 14 (100) 0 (0) 0 (0)




119 114 (96) 5 (4) 0 (0)
Bronchoscopy Tracheobronchial 94 89 (95) 2 (2) 3 (3)
Sputum induction Tracheobronchial 64 60 (94) 2 (3) 2 (3)
Manual ventilation Tracheobronchial 56 52 (93) 2 (4) 2 (4)
Airway suctioning Tracheobronchial, 
oronasal
103 92 (89) 6 (6) 5 (5)
Cardiopulmonary resuscitation Tracheobronchial 74 66 (89) 3 (4) 5 (7)
Tracheostomy and tracheostomy 
procedures
Tracheobronchial 65 57 (88) 8 (12) 0 (0)
Non- invasive ventilation Tracheobronchial 89 78 (88) 8 (9) 3 (3)
High- flow oxygen therapy Inhaled therapy 37 32 (86) 4 (11) 1 (3)
Breaking closed ventilation 
systems (intentionally or 
unintentionally)
Tracheobronchial 13 11 (85) 2 (15) 0 (0)
Nebulised or aerosol therapy Inhaled therapy 91 75 (82) 9 (10) 7 (8)
Nasopharyngoscopy or 
laryngoscopy
Oronasal 16 12 (75) 2 (13) 2 (13)
High- frequency oscillatory 
ventilation
Tracheobronchial 39 27 (69) 9 (23) 3 (8)
Coughing Tracheobronchial 18 10 (55) 5 (28) 3 (17)
Mechanical ventilation Tracheobronchial 15 8 (53) 4 (27) 3 (20)
Chest physiotherapy Tracheobronchial 46 23 (50) 14 (30) 9 (20)
Nasopharyngeal aspirate Oronasal 29 13 (45) 12 (41) 4 (14)
Percentages were rounded to the nearest full percentage point.
Table 4 Procedure groups with high levels of disagreement among sources on aerosol- generating status
Procedure group Aerosol source




n (%) of sources 
that classified 
procedures in this 
group as aerosol- 
generating
n (%) of sources 
that classified 
procedures in this 
group as possibly 
aerosol- generating
n (%) of sources 
that classified 
procedures in 
this group as not 
aerosol- generating





10 5 (50) 2 (20) 3 (30)




14 4 (29) 2 (14) 8 (57)
Nasopharyngeal and 
oropharyngeal swabbing
Oronasal 34 9 (27) 10 (29) 15 (44)
Percentages were rounded to the nearest full percentage point.
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aerosol- generating, possibly aerosol- generating or not 
aerosol- generating. However, the small number of source 
documents for these procedure groups means that no 
firm conclusions can be drawn.
DISCUSSION
This rapid systematic review has produced a number 
of key findings. First, we have reduced a lengthy list of 
procedures to 39 procedure groups, making the classifi-
cation of such procedures easier. We have also developed 
a taxonomy of the likely sources of aerosols.
Second, we believe we have identified a substantial 
body of relevant literature and that this has allowed us to 
draw reasonably confident conclusions as to which proce-
dures have been most frequently identified as being 
aerosol- generating.
Third, through a thorough search and synthesis of this 
literature, we have identified a number of procedures 
on which there is already high consensus that these 
are aerosol- generating or possibly aerosol- generating. 
In view of the seriousness of COVID-19 and the known 
occupational risk to healthcare workers, we recommend 
that the procedures listed in table 3 be treated as aerosol- 
generating procedures for the purposes of selecting 
personal protective equipment.
Fourth, we have identified a list of potential aerosol- 
generating procedures on which guidance appears 
to be sparse. Of particular note is the fact that certain 
very common procedures (such as colonoscopy and 
procedures relating to labour and delivery) were barely 
mentioned in our sample of 128 documents. It is possible 
that our search missed specialist publications, so a logical 
next step would be more specific searches for these proce-
dures. If dependable literature addressing these cannot 
be identified, we recommend that professional and regu-
latory bodies note the list of procedures presented in 
table 4 and hold meetings to establish the current level 
of multidisciplinary professional consensus.
Finally, we have identified a small number of proce-
dures (shown in table 4) on which there appears to be 
substantial disagreement. The groups ‘oral and dental 
procedures’ and ‘thoracic surgery and procedures’ were 
broad and each covered a range of procedures. Upper 
GI endoscopy was covered by only 10 documents, so 
more specific searching and arriving at expert consensus 
may be indicated for this procedure group, too. For 
the other contested procedure group (nasopharyngeal 
and oropharyngeal swabbing), we recommend that a 
process of achieving expert consensus be used, such as 
a modified Delphi method among a panel of relevant 
Table 5 Procedure groups with limited evidence (<10 sources)
Procedure group
Aerosol source
(if procedures aerosol- 
generating or possibly 
aerosol- generating)




n (%) of sources 
that classified 
procedures in this 
group as aerosol- 
generating
n (%) of sources 
that classified 
procedures in this 
group as possibly 
aerosol- generating
n (%) of sources 
that classified 
procedures in 
this group as not 
aerosol- generating
ENT and neurosurgery Wound/invasive 
procedure
3 3 (100) 0 (0) 0 (0)
GI endoscopy (not further 
specified)
GI (not further specified) 2 2 (100) 0 (0) 0 (0)
Intra/extra pulmonary high- 
frequency oscillation devices
Tracheobronchial 3 2 (67) 1 (33) 0 (0)
Toilet use and flushing Cleaning tasks 2 2 (100) 0 (0) 0 (0)
Vacuum cleaning Cleaning tasks 2 2 (100) 0 (0) 0 (0)
Supraglottic airways Tracheobronchial 1 1 (100) 0 (0) 0 (0)
Handling soiled laundry Cleaning tasks 6 5 (83) 0 (0) 1 (17)
Prone positioning Tracheobronchial 5 4 (80) 0 (0) 1 (20)
Mechanical insufflation and 
exsufflation
Tracheobronchial 4 3 (75) 1 (25) 0 (0)
Manipulation of masks Oronasal 8 5 (63) 0 (0) 3 (37)
Lung function testing Tracheobronchial 7 4 (57) 2 (29) 1 (14)
Suction of body fluids (not 
further specified)
Patient care 6 3 (50) 2 (33) 1 (17)
Colonoscopy Lower GI 2 1 (50) 0 (0) 1 (50)
Nasogastric tube insertion Oronasal 9 4 (44) 1 (11) 4 (44)
Nitrous oxide (Entonox) 
administration
– 2 0 (0) 0 (0) 2 (100)
Labour and delivery – 1 0 (0) 0 (0) 1 (100)
Percentages were rounded to the nearest full percentage point. Totals may therefore not equal 100% exactly.
ENT, ear, nose and throat; GI, gastrointestinal.
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experts who examine each of our 34 sources individually, 
ideally supplemented by an updated literature search.21 
Strengths of our paper include an extensive literature 
search, yielding a dataset that covers both academic and 
grey literature and also a very wide range of settings, 
authorities and jurisdictions. Furthermore, all data 
were at least double- checked. We believe this is the first 
systematic, international survey of guidance on aerosol- 
generating procedures.
This study has a number of limitations. The chief limita-
tion is that we were working from secondary sources and 
were not resourced to go back to primary evidence on 
which recommendations would have been based. While 
we can have some confidence in widespread agreement 
among experts that a procedure is aerosol- generating, 
the reverse is not necessarily true. It is possible that 
procedures not listed in guidance documents as aerosol- 
generating may still produce aerosols, especially when 
those procedures are relatively new or where there 
has been no specific research to confirm or refute the 
hypothesis. The list in table 3 should therefore not be 
viewed as exhaustive.
Additionally, we could have categorised the various, 
slightly differing, descriptions of procedures that we 
found in the included source documents in a number 
of ways. While the procedure groups and aerosol sources 
described in our review represent the consensus of a 
diverse set of authors with expertise in the subject matter, 
in evidence synthesis methodology, and in medical 
taxonomy, our groupings are, in a sense, arbitrary and 
various different schemata may be equally valid.
Moreover, the frequency counting approach is at best 
an approximation of expert consensus; we counted each 
mention equally, but perhaps should not have. The docu-
ments we included were addressed to different audi-
ences, developed with varying degrees of scholarly rigour, 
and they were sometimes based on one another or based 
on common sources.
We did not undertake a formal risk of bias assessment 
of our included documents, partly because no suitable 
tool could be identified and partly because our objective 
was to map the variation in recommendations across the 
full range of official guidance.
As noted above, some clinically relevant procedures 
received surprisingly little mention in our source docu-
ments. We therefore cannot conclude that our search, 
extensive as it was, led to a classification of aerosol- 
generating procedures that is complete for all clinical 
situations. In particular, colonoscopy as well as labour 
and delivery procedures will clearly require further 
exploration. There were other infrequently mentioned 
procedures which are performed in healthcare settings 
but are not medical in nature, such as vacuum cleaning 
and toilet flushing; these may nonetheless be relevant 
and would also require further specific attention.
The reader will also note that we found more Canadian 
resources than one might expect from Canada’s share of 
the global economy and population. Likely, we fell victim 
to a degree of ‘home country bias’—we searched glob-
ally, but our familiarity with Canadian resources may 
have meant that we have identified those more readily 
than others. We caution the reader to consider this, but 
at the same time want to propose that Canada can serve 
as a model Western society and that the considerations of 
Canadian health services are also applicable elsewhere.
A number of findings from this review prompt new 
hypotheses that should be taken forward. One theme 
that emerged, for example, is that various procedures 
deemed to be aerosol- generating were suggested to have 
the potential to trigger coughing, and coughing in itself 
was characterised as aerosol- generating in multiple source 
documents. For such procedures, triggering a cough 
might therefore be the mode of aerosol generation.
In this context, it is worth noting that coughing can 
aerosolise viruses. Jones and Brosseau proposed a model 
for evaluating the quality of evidence for aerosol trans-
mission of an infectious disease, with three conditions: 
aerosol generation (containing pathogens), environ-
mental viability, and access to target tissue (resulting in 
infection).22 They found that there was strong evidence 
for aerosol transmission of influenza and severe acute 
respiratory syndrome (SARS), among other diseases. We 
can therefore draw from the literature on influenza and 
SARS with some confidence of its generalisability. There 
is specific evidence that influenza may be transmitted by 
coughing, which Huynh et al found to produce airborne 
particles containing viable virus; these particles can then 
be inhaled by others, especially in close proximity.23 
Lindsley et al examined exposure from coughing using 
breathing and coughing simulators and found that the 
breathing simulator would incur substantial exposure at 
a distance of 46 cm from the coughing simulator, but that 
distancing to 183 cm could reduce exposure by 92%.24 
However, another study using the same methodology 
demonstrated that cough particles spread throughout 
a room within several minutes, meaning anyone in the 
room may be exposed regardless of their location.6
Recent work in fluid dynamics has suggested that 
longstanding assumptions about how aerosols are gener-
ated, that is, that coughs produce aerosolised particles 
of respiratory secretions expelled in a direct trajectory, 
may underestimate the exposure risk. We now know that 
coughs and sneezes are primarily composed of turbu-
lent gas clouds which contains droplets of various sizes, 
and which can travel 7–8 m.7 Van Doremalen et al inves-
tigated the aerosol and surface stability of SARS- CoV-2 
and compared it with SARS- CoV (the virus that causes 
SARS), finding them similar, supportive of aerosol and 
fomite transmission.5
If any procedure that triggers coughing is potentially 
associated with the generation of aerosols, the impli-
cations for personal protective equipment during the 
COVID-19 pandemic are profound, especially since 
coughing is a common symptom of COVID-19.17 A study 
assessing the efficacy of different protective equipment 
showed that N95 respirators were effective protection 
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against aerosol exposure from a close- range cough, 
while surgical masks were inadequate.12 Other laboratory 
studies have shown similar findings, notably that higher- 
grade personal protective equipment (N95 respirators) 
worn by both patients and healthcare workers reduced 
exposure to such particles.5
While the debate about aerosol- generating procedures 
in the context of COVID-19 has focused primarily on the 
question of when and how healthcare workers should 
select respirators, there are many other measures that 
should be taken to reduce viral transmission when under-
taking a healthcare procedure or exposure that could 
generate aerosols. Systems- level modifications to facilities 
include optimising air ventilation and decreasing relative 
humidity.25 Experiments with aerosolised SARS- CoV-2 
in artificial saliva have shown it to be twice as stable as 
influenza at medium humidity (40%–60%), and to have 
longer viability in high humidity (68%–88%) compared 
with lower humidities.26 Interventions clinicians can 
undertake personally include self- distancing (eg, from a 
coughing patient) and careful doffing of personal protec-
tive equipment. Consideration should also be given to 
continuous masking by staff and patients.27
In conclusion, this rapid systematic review has added 
to the evidence base for the classification of aerosol- 
generating procedures. While the literature has many 
gaps, we believe that there is sufficient evidence to confi-
dently classify at least 19 procedure groups as aerosol- 
generating. To reduce dissent on the remainder, we 
recommend that (a) clinicians define procedures more 
clearly and specifically, breaking them down into their 
constituent components where possible; (b) researchers 
undertake further studies of aerosolisation during these 
procedures; and (c) guideline- making and policy- making 
bodies address a wider range of procedures.
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